Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006415-74Phase 3Completed
Phase 3, randomised, double-blind trial of losartan, amlodipine and Placebo-COD Research Private Ltd in proteinuria (4 arms), sponsored by MSD. Primary endpoint: Reduction of proteinuria. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006415-74.